08045804946
Send Inquiry
AHABIR 500MG TABS
5000.0 INR/Vial
Product Details:
- Indication Metastatic castration-resistant prostate cancer (mCRPC)
- Salt Composition Abiraterone Acetate
- Origin of Medicine India
- Brand Name AHABIR
- Pacakaging (Quantity Per Box) 60 tablets
- Packaging Type Bottle
- Dosage Form Oral tablet
- Click to View more
X
AHABIR 500MG TABS Price And Quantity
- 5000.0 INR/Vial
- 1 Number
- Hypersensitivity to Abiraterone or any component of the formulation
- White to off-white
- Hetero Healthcare Limited
- Oval
- Prescription only
- Oral
- L02BX03
- Hypertension, hypokalemia, fluid retention, increased liver enzymes
- 24 months
AHABIR 500MG TABS Product Specifications
- Tablets
- Oral tablet
- Allopathic
- As directed by physician
- Antineoplastic/Anticancer
- 24 months from manufacturing date
- 60 tablets per bottle
- Once daily on an empty stomach or as prescribed
- Bottle
- Prostate Cancer Treatment
- Adults
- Metastatic castration-resistant prostate cancer (mCRPC)
- Store below 30C, protected from moisture
- Abiraterone Acetate
- Abiraterone Acetate 500mg
- 60 tablets
- India
- AHABIR
- Hypersensitivity to Abiraterone or any component of the formulation
- White to off-white
- Hetero Healthcare Limited
- Oval
- Prescription only
- Oral
- L02BX03
- Hypertension, hypokalemia, fluid retention, increased liver enzymes
- 24 months
AHABIR 500MG TABS Trade Information
- Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID)
- 1000 Number Per Week
- 2 Days
- No
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Africa, Middle East
- All India
Product Description
- Active Ingredient: Abiraterone acetate (500 mg strength).
- Primary Use: Treatment of metastatic castration-resistant prostate cancer (cancer that has spread and not responded to other hormonal therapy) and metastatic castration-sensitive prostate cancer.
- Mechanism: It is an androgen biosynthesis inhibitor, meaning it blocks the production of androgens (male hormones).
- Administration: It is an oral tablet taken once daily on an empty stomach, at least one hour before or two hours after a meal. The tablets must be swallowed whole and not crushed or chewed.
- Combination Therapy: It is typically prescribed in combination with a steroid medication, such as prednisolone or prednisone, to manage potential side effects like high blood pressure, fluid retention, and low potassium levels.
- Prescription Drug: Ahabir 500 mg is a prescription-only medication and should be used under proper medical guidance and advice.
Targeted Therapy for Prostate Cancer
AHABIR 500MG Tablets are dedicated to managing metastatic castration-resistant prostate cancer, helping to slow cancer progression by selectively inhibiting androgens vital to tumor growth. This targeted approach maximizes therapeutic effect while aiming to minimize non-cancerous tissue impact. Patients benefit from a well-established regimen administered under medical supervision.
Safe and Effective Administration
Each dose of AHABIR should be taken once daily on an empty stomach, as food can affect absorption. The tablets must be swallowed whole with water and taken at the same time each day. Close monitoring by a physician ensures that dosing and side effects are managed appropriately throughout the course of treatment.
FAQ's of AHABIR 500MG TABS:
Q: How should AHABIR 500MG Tablets be taken for optimal effectiveness?
A: AHABIR 500MG Tablets should be taken once daily on an empty stomach, at least two hours after eating and one hour before the next meal, or as prescribed by your physician. Swallow the tablet whole with water and do not crush or chew.Q: What is the primary benefit of using AHABIR 500MG Tablets?
A: The main benefit of AHABIR 500MG Tablets is to inhibit cancer progression in patients with metastatic castration-resistant prostate cancer (mCRPC), effectively slowing tumor growth by blocking androgen production essential for cancer cell proliferation.Q: When should I contact my doctor during treatment with AHABIR 500MG Tablets?
A: You should contact your doctor promptly if you experience symptoms such as high blood pressure, unusual swelling, weakness, muscle cramps, or dark urine, as these may indicate common side effects like hypertension, hypokalemia, fluid retention, or increased liver enzymes.Q: What precautions should be taken regarding the storage of AHABIR 500MG Tablets?
A: AHABIR 500MG Tablets must be stored below 30C and kept protected from moisture in their original packaging. Ensure the bottle is tightly closed and away from children and direct sunlight for optimal shelf life.Q: Who should avoid using AHABIR 500MG Tablets?
A: Individuals with known hypersensitivity to Abiraterone or any ingredient in the formulation must not use AHABIR. Always consult your healthcare provider for a full assessment before beginning therapy.Q: What process should I follow if I miss a dose of AHABIR 500MG Tablets?
A: If you miss a dose, take it as soon as you remember unless it is close to the next scheduled dose. Do not take a double dose to make up for the missed one. Continue with your regular dosing schedule and notify your physician if you miss multiple doses.Q: Where can I obtain AHABIR 500MG Tablets?
A: AHABIR 500MG Tablets are available strictly by prescription and should be purchased from licensed pharmacies or authorized medical suppliers. Always use the medicine under the supervision of a qualified healthcare professional.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMS
Call Me FreeMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
